Bespoke Extracts (BSPK) Liabilities and Shareholders Equity (2011 - 2025)

Bespoke Extracts' (BSPK) quarterly Liabilities and Shareholders Equity came in at $295573.0 in Q3 2025, down 12.56% year-on-year from $338015.0 in Q3 2024, and up 10.69% quarter-over-quarter from $267038.0 in Q2 2025.

Bespoke Extracts (BSPK) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends

Bespoke Extracts has disclosed Liabilities and Shareholders Equity across 15 years of filings, most recently posting $295573.0 for Q3 2025.

  • Liabilities and Shareholders Equity for Q3 2025 came in at $295573.0, down 12.56% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.2 million (down 17.37% YoY), and the FY2024 annual result was $359088.0, up 1.33% from the prior year.
  • Liabilities and Shareholders Equity came in at $295573.0 for Q3 2025 at Bespoke Extracts, up from $267038.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $646520.0 in Q1 2021 to a low of $67106.0 in Q4 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $359088.0 (2024), against an average of $354638.1.
  • Peak annual rise in Liabilities and Shareholders Equity reached 530.08% in 2021, while the deepest fall reached 79.98% in 2021.
  • Bespoke Extracts' Liabilities and Shareholders Equity stood at $67106.0 in 2021, then jumped by 510.36% to $409591.0 in 2022, then slipped by 13.48% to $354360.0 in 2023, then rose by 1.33% to $359088.0 in 2024, then slipped by 17.69% to $295573.0 in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $295573.0 (Q3 2025), $267038.0 (Q2 2025), and $248125.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Bespoke Extracts - - 234,175.00 295,573.00

Historic Data

Download Data
DateValue
Sep 30, 2025 295,573.00
Jun 30, 2025 267,038.00
Mar 31, 2025 248,125.00
Dec 31, 2024 359,088.00
Sep 30, 2024 338,015.00
Jun 30, 2024 367,477.00
Mar 31, 2024 355,836.00
Dec 31, 2023 354,360.00
Sep 30, 2023 388,109.00
Jun 30, 2023 448,286.00
Mar 31, 2023 478,509.00
Dec 31, 2022 409,591.00
Sep 30, 2022 369,636.00
Jun 30, 2022 404,628.00
Mar 31, 2022 522,550.00
Nov 30, 2021 67,106.00
Aug 31, 2021 124,520.00
May 31, 2021 293,157.00
Feb 28, 2021 646,520.00
Nov 30, 2020 335,247.00